Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's ...
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
Stargate is little more than an extension of Sam Altman's powerful AI company, anonymous sources told the Financial Times.
Sam Altman has told OpenAI fans to lower their expectations after rumors the company had achieved AGI went viral on X.
OpenAI, Oracle and Soffbank pledged to build up to $500 billion worth of data centers in the U.S. after a President ...